Risk Factors Associated with Hyporesponsiveness to Erythropoietin in Chronic Kidney Disease Patients on Hemodialysis Who Present Anemia: A Multicenter Case-Control Study

Background: Anemia represents a significant complication in patients with advanced chronic kidney disease (CKD) on hemodialysis, primarily caused by reduced renal erythropoietin production. Despite erythropoiesis-stimulating agents (ESAs) being the cornerstone of treatment, hyporesponsiveness to the...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlos Perez Tulcanaza, André Benítez-Baldassari, Andrea Banegas-Sarmiento, Jose Daniel Sanchez
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Kidney and Dialysis
Subjects:
Online Access:https://www.mdpi.com/2673-8236/5/2/23
Tags: Add Tag
No Tags, Be the first to tag this record!